Evidence mapPaperPMID 42593504Full record

ReviewInternational urogynecology journal2026

Fractional CO

Ebru Zulfikaroglu, Baris Zulfikaroglu

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ebru ZulfikarogluEva Women Health Clinic, Ankara, Turkey. zebru33@gmail.com.ORCID http://orcid.org/0000-0002-2279-1822
Baris ZulfikarogluUniversity of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4782-0308

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisGenitourinary syndrome of menopause (GSM) is common and may persist despite first-line measures. Fractional CO

methodsWe systematically reviewed clinical studies and restricted quantitative synthesis to CO

resultsThirty-six clinical studies involving 1,709 participants, including 11 randomized controlled trials and 407 cancer survivors, met the inclusion criteria. Quantitative synthesis included nine CO

conclusionsFractional CO

Indexed as

Fractional CO2 laserGenitourinary syndrome of menopauseMeta-analysisSexual functionUrinary symptomsVulvovaginal atrophy

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.